Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Lorenzo Bosque, AAPOS 2021: Effect of Dichoptic Digital Therapeutic for Amblyopia: A Randomized Controlled Trial

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 4th 2021

Lorenzo Bosque (Boston University School of Medicine, Boston, MA, USA) told us about his study evaluating a new retinal polarisation scanning-based vision screening device, its findings and future studies.

Questions

  1. Could you tell us about your study evaluating the new retinal polarisation scanning-based vision screening device? (00:12)
  2. What were the findings of this study? (01:09)
  3. What unanswered questions remain and what future studies are planned? (02:30)

Speaker Disclosure: Lorenzo Bosque has no financial or non-financial relationships or activities to declare in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of AAPOS 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup